Showing 1 - 1 results of 1 for search 'Hiroshi Takei', query time: 0.01s Refine Results
  1. 1
    Interleukin-17A is a potential therapeutic target predicted by proteomics for systemic sclerosis patients at high risk of pulmonary arterial hypertension

    Interleukin-17A is a potential therapeutic target predicted by proteomics for systemic sclerosis patients at high risk of pulmonary arterial hypertension by Yuuichi Ono, Akira Mogami, Ryuta Saito, Noriyasu Seki, Sho Ishigaki, Hiroshi Takei, Keiko Yoshimoto, Kenji Chiba, Tsutomu Takeuchi, Yuko Kaneko

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: